GOALS & OBJECTIVES
DOES AN ASPIRIN A DAY
Paper Symposium
Activity Date: June 2003  — Activity Info: Volume3, (6B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide a guide for the selection of gastroprotective strategies for the patient requiring continued inflammatory pain management.

TARGET AUDIENCE
This activity is designed for medical directors and pharmacy directors of managed care plans, pharmacy and therapeutic committee members, and all hospital-based managed care decision makers. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. At the conclusion of this activity, participants should be able to:

  • Review the clinical and economic impact of gastrointestinal events related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Identify patient risk factors for NSAID-related adverse gastrointestinal events.
  • Discuss the impact of aspirin on NSAID-related adverse gastrointestinal events and its importance when choosing regimens to prevent their occurrence.
  • Discuss available treatments aimed at decreasing gastrointestinal toxicity in chronic NSAID users.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 2 hours.

Release date: June 15, 2003. Expiration date: June 15, 2005.

This program is approved for 2 hours (0.2 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE Program# 064-999-03-203-H01.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an educational grant from TAP Pharmaceutical Products, Inc.

Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, a division of Advanced Studies in Medicine, an HMG Company. PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2003 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC.

     
Home | Contact Us | View Account | Need Help?